Matthew Ronsheim, Chief of Pharma Sciences & MFG at Entasis Therapeutics Holdings, holds 40.78K shares in Innoviva (Ticker: INVA), holds 0.00 shares in Entasis Therapeutics Holdings (Ticker: ETTX).

See the Hottest Stocks Based on Insider Trading >

Matthew Ronsheim
Entasis Therapeutics Holdings (ETTX)
Chief of Pharma Sciences & MFG

Not Ranked

Matthew Ronsheim has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

INVA

A breakdown of Matthew Ronsheim's holdings

See the Top Stocks by Insiders

Insider Roles

Innoviva
(INVA)

wholly owned subsidiary of Innoviva Specialty Therapeutics Holdings, LLC, which is a wholly owned subsidiary of Innoviva, Inc

Roles that Matthew Ronsheim holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Matthew Ronsheim

See the Latest Stocks Traded by Insiders

Matthew Ronsheim's Trading History

ETTX

Entasis Therapeutics Holdings

Jul 11, 2022

―

Uninformative Sell

38.66K

$0.00

INVA

Innoviva

Mar 07, 2024

wholly owned subsidiary of Innoviva Specialty Therapeutics Holdings, LLC, which is a wholly owned subsidiary of Innoviva, Inc

Uninformative Buy

189.99K

$619.83K

List of latest transactions for each holding click on a transaction to see Matthew Ronsheim's performance on stock

See All Insider Trading from Today

Matthew Ronsheim insider profile FAQ

What is the percentage of profitable transactions made by Matthew Ronsheim?

The percentage of profitable transactions made by Matthew Ronsheim is ―.

What is the average return per transaction made by Matthew Ronsheim?

The average return per transaction made by Matthew Ronsheim is ―.

What stocks does Matthew Ronsheim hold?

Matthew Ronsheim holds: ETTX, INVA stocks.

What was Matthew Ronsheim’s latest transaction?

Matthew Ronsheim latest transaction was an Uninformative Buy of $189.99K.

What was Matthew Ronsheim's most profitable transaction?

Matthew Ronsheim’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Matthew Ronsheim's role in Entasis Therapeutics Holdings?

Matthew Ronsheim's role in Entasis Therapeutics Holdings is Chief of Pharma Sciences & MFG.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Matthew Ronsheim Insider Profile

Matthew Ronsheim Entasis Therapeutics Holdings (ETTX)Chief of Pharma Sciences & MFG